I must point out again your projection is not earnings to IPCI .... but revenue to IPCI for Seroquel.
Are you factoring in IPCI manufacturing for Seroquel ..... on cost plus basis ...... which means they generate revenue in excess of cost on each pill produced ...... then later splitting profit with the partner on final sales ?
Seroquel ANDS was also submitted to Health Canada. Be doubly nice if Health Canada also got on the approval train for Canada.